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BACKGROUND: Acute exercise does not elicit compensatory changes in appetite parameters in lean individuals; however, less is
known about responses in overweight individuals. This study compared the acute effects of moderate-intensity exercise on
appetite, energy intake and appetite-regulatory hormones in lean and overweight/obese individuals.
METHODS: Forty-seven healthy lean (n= 22, 11 females; mean (s.d.) 37.5 (15.2) years; 22.4 (1.5) kg m− 2) and overweight/obese
(n= 25, 11 females; 45.0 (12.4) years, 29.2 (2.9) kg m− 2) individuals completed two, 8 h trials (exercise and control). In the exercise
trial, participants completed 60 min treadmill exercise (59 (4)% peak oxygen uptake) at 0–1 h and rested thereafter while
participants rested throughout the control trial. Appetite ratings and concentrations of acylated ghrelin, peptide YY (PYY) and
glucagon-like peptide-1 (GLP-1) were measured at predetermined intervals. Standardised meals were consumed at 1.5 and 4 h and
an ad libitum buffet meal was provided at 7 h.
RESULTS: Exercise suppressed appetite (95% conﬁdence interval (CI) − 3.1 to − 0.5 mm, P= 0.01), and elevated delta PYY (95% CI 10
to 17 pg ml− 1, Po0.001) and GLP-1 (95% CI 7 to 10 pmol l− 1, Po0.001) concentrations. Delta acylated ghrelin concentrations
(95% CI −5 to 3 pg ml− 1, P= 0.76) and ad libitum energy intake (95% CI − 391 to 346 kJ, P= 0.90) were similar between trials.
Subjective and hormonal appetite parameters and ad libitum energy intake were similar between lean and overweight/obese
individuals (P⩾ 0.27). The exercise-induced elevation in delta GLP-1 was greater in overweight/obese individuals (trial-by-group
interaction P= 0.01), whereas lean individuals exhibited a greater exercise-induced increase in delta PYY (trial-by-group interaction
Po0.001).
CONCLUSIONS: Acute moderate-intensity exercise transiently suppressed appetite and increased PYY and GLP-1 in the hours after
exercise without stimulating compensatory changes in appetite in lean or overweight/obese individuals. These ﬁndings underscore
the ability of exercise to induce a short-term energy deﬁcit without any compensatory effects on appetite regardless of weight
status.
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INTRODUCTION
The impact of exercise on energy balance is inﬂuenced by its
effects on appetite regulation and food intake. Evidence suggests
that acute moderate- to high-intensity exercise transiently
suppresses appetite in healthy, lean individuals, which occurs
with commensurate ﬂuctuations in appetite-regulatory hormones,
including acylated ghrelin, peptide YY (PYY) and glucagon-like
peptide-1 (GLP-1).1,2 These responses are transient, typically
returning to resting control values in the hours after exercise
and do not inﬂuence energy intake at meals on the day of
exercise.1–3 This lack of compensatory response highlights the
ability of exercise to induce a short-term energy deﬁcit and
modulate weight control.
Considering obesity is characterised by a chronic surplus of
energy intake above expenditure, it is conceivable that appetite
responses to exercise may differ between lean and overweight/
obese individuals. Previous non-exercise studies have demon-
strated that postprandial increases in circulating satiety hormones
(PYY and GLP-1) are blunted in obese compared with lean
individuals,4,5 and obese individuals exhibit lower fasting con-
centrations and reduced postprandial suppression of the orexi-
genic hormone ghrelin.6 Despite these divergent responses, few
studies have investigated the acute effects of exercise on appetite
regulation in overweight/obese compared with lean individuals.
Current evidence suggests that acute exercise does not
stimulate any immediate compensatory changes in appetite,
energy intake or appetite-regulatory hormones in overweight or
obese individuals.7–10 A direct comparison of lean and over-
weight/obese individuals identiﬁed a similar transient elevation in
total PYY and GLP-17–36 concentrations up to 1 h after exercise in
both groups that occurred without simultaneous changes in
acylated ghrelin or appetite.11 Furthermore, ad libitum energy
intake in the immediate postexercise period appears unaffected12
or reduced11 in lean and overweight/obese individuals. However,
additional research is required to understand and compare the
appetite regulation of lean and overweight/obese individuals in
response to acute exercise, including examination of responses
beyond the immediate postexercise period (41 h). This
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information is important for elucidating the impact of exercise on
appetite regulation in a clinically relevant population.
Therefore, the aim of this study was to examine the appetite, ad
libitum energy intake and appetite-regulatory hormone responses
during and for 7 h after an acute bout of moderate-intensity
exercise in healthy lean and overweight/obese individuals.
METHODS
This study received approval from the NHS East Midlands Research Ethics
Committee (13/EM/0290) prior to its initiation and was conducted in
accordance with good clinical practice guidelines and the Declaration of
Helsinki.13
Participants
Sixty participants provided written informed consent to participate in this
study. All participants were metabolically healthy, not taking any
medications, body mass stable for ⩾ 3 months (±2 kg) and non-smokers.
Participants were ‘inactive’ or ‘moderately active’ according to the
International Physical Activity Questionnaire,14 had no abnormal eating
behaviour traits15 and had a body mass index (BMI) between 18.5–
24.9 kg m− 2 and 25.0–39.9 kg m− 2. Female participants were either
premenopausal or postmenopausal and not pregnant. Thirteen partici-
pants withdrew before completing all trial visits. Consequently, data are
reported for 47 participants in this manuscript (lean n= 22, BMI range 19.6–
24.5 kg m− 2 (males n= 11; females n=11); overweight/obese n= 25, BMI
range 25.3–35.4 kg m− 2 (males n= 14; females n=11)). Table 1 details the
key participant characteristics.
Preliminary testing
Participants completed two preliminary visits to conﬁrm eligibility,
determine peak oxygen uptake (V˙O2) and familiarise themselves with
main trial procedures. The eligibility assessment included a full medical
evaluation with blood screen (Table 1) and cardiovascular risk assessment.
Eligible participants completed treadmill-based submaximal incremental
and peak V˙O2 tests as described previously.
16 Oxygen consumption and
carbon dioxide production were determined using an online breath-by-
breath gas analysis system (Metalyser 3B, Cortex, Biophysik, Germany).
Experimental procedures
Participants completed two, 8 h (0900–1700 hours) trials (control and
exercise) in a randomised crossover design. Main trials were separated by
at least 7 days for men and 28 days for women to standardise for
menstrual cycle phase. In the 48 h before trials, participants standardised
their diets using a weighed food diary and did not consume any alcohol or
caffeinated drinks. Participants also refrained from strenuous physical
activity and consumed a prescribed meal on the evening before each main
trial. The meal, consisting of pasta, tomato sauce and chocolate biscuits,
provided 3138 kJ for males and 2820 kJ for females (71% carbohydrate,
11% protein, 18% fat). After this meal, only water was permitted until the
beginning of main trials.
At the beginning of the exercise trial (0− 1 h), participants completed
60 min of treadmill exercise at a speed predicted to elicit 60% peak V˙O2
and then rested within the laboratory for the subsequent 7 h. An online
breath-by-breath gas analysis system was used to estimate energy
expenditure and maintain exercise intensity, with accompanying measure-
ments of heart rate (Model T31 Polar, Kempele, Finland) and ratings of
perceived exertion.17 Identical procedures were undertaken in the control
trial except no exercise was performed. Instead, resting expired air samples
were collected in a semisupine position to permit the calculation of net
energy expenditure during the exercise bout using the equations of
Frayn.18
Appetite, food provision and ad libitum energy intake
During each trial, appetite ratings (hunger, satisfaction, fullness and
prospective food consumption) were assessed at baseline and every
30 min thereafter using 100 mm visual analogue scales.19 An overall
appetite rating was quantiﬁed as the mean value of the four appetite
ratings after satisfaction and fullness were reverse-scored.20 At 1.5 h
(~1030 hours), participants consumed a standardised breakfast consisting
of jam sandwiches (brown bread, margarine and strawberry jam), banana
and orange juice. The energy content of this meal was 2690 kJ for males
and 2418 kJ for females (72% carbohydrate, 10% protein, 18% fat). At 4 h
(~1300 hours), participants consumed a standardised lunch consisting of
either tuna and mayonnaise or cheese white bread sandwiches, salted
crisps, apple and a chocolate mufﬁn. The energy content of this meal was
3138 kJ for males and 2820 kJ for females (43% carbohydrate, 32% protein,
25% fat). Each meal was consumed within 15 min.
Energy and macronutrient intakes were assessed at an ad libitum buffet
meal provided at 7 h (~1600 hours) during main trials. The items available
were: white bread, brown bread, apples, bananas, margarine, ham, cheese,
tuna, mayonnaise, crisps, chocolate rolls, cereal bars, cookies, and
chocolate mufﬁns. The buffet foods were presented identically on each
occasion in excess of expected consumption. Participants were given
30 min to eat until they were ‘comfortably full’. Participants consumed
meals in isolation so that social inﬂuence did not affect eating rate, food
selection or quantity eaten. Manufacturer values were applied to the
weight of foods consumed to determine energy and macronutrient
intakes.
Blood sampling and biochemical analysis
Fasting capillary blood samples were collected during the preliminary
testing to determine plasma concentrations of glucose (Accutrend Plus,
Roche, Switzerland), total cholesterol, high-density lipoprotein cholesterol
and triacylglycerol (CardioChek, PTS Diagnostics, Indianapolis, IN, USA).
Low-density lipoprotein cholesterol concentration was estimated.21
During main trials, venous blood samples were collected via a cannula
(Venﬂon, Becton Dickinson, Helsingborg, Sweden) inserted into an
Table 1. Participant characteristics
Lean (n=22) Overweight/obese (n= 25) Lean vs overweight/obese 95% CIa Effect size
Age (years) 37.5 (15.2) 45.0 (12.4) − 0.6 to 15.6 0.55
Body mass (kg) 63.7 (7.9) 86.5 (14.5) 15.9 to 29.8b 1.92
Body mass index (kg m− 2) 22.4 (1.5) 29.2 (2.9) 5.4 to 8.2b 2.87
Waist circumference (cm) 75.7 (7.6) 91.8 (9.5) 11.1 to 21.3b 1.87
Peak V̇O2 (ml kg
− 1 min− 1) 43.6 (12.2) 34.7 (8.9) − 15.1 to − 2.7b 0.84
Peak V̇O2 (l min
− 1) 2.83 (0.91) 2.99 (0.86) − 0.36 to 0.68 0.18
Fasting glucose (mmol l− 1) 4.72 (0.82) 4.70 (0.94) − 0.54 to 0.50 0.03
Fasting TC (mmol l− 1) 3.89 (1.08) 4.77 (1.40) 0.14 to 1.63b 0.70
Fasting HDL-C (mmol l− 1) 2.00 (0.59) 1.48 (0.55) − 0.86 to − 0.19b 0.93
Fasting LDL-C (mmol l− 1) 1.62 (1.12) 2.96 (1.43) 0.59 to 2.11b 1.04
Fasting TAG (mmol l− 1) 1.12 (0.86) 1.65 (1.04) − 0.04 to 1.09 0.55
Fasting leptin (pg ml− 1) 8273 (9119) 15 340 (9984) 1420 to 12 713b 0.74
Abbreviations: CI, conﬁdence interval; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TAG, triacylglycerol; TC, total
cholesterol; V̇O2, oxygen uptake. All values are mean (s.d).
a95% conﬁdence interval of the mean absolute difference between the groups. bSigniﬁcant
difference between lean and overweight/obese individuals (Po0.05).
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antecubital vein. Blood samples were collected into prechilled EDTA
monovettes (Sarstedt, Leicester, UK) for the determination of plasma
acylated and desacylated ghrelin, total PYY, total GLP-1, insulin and
glucose at baseline (fasting), 1, 1.5, 2.25, 2.75, 3.25, 4, 4.75, 5.25, 5.75, 7 and
8 h. The monovettes for acylated ghrelin also contained protease inhibitors
to prevent the degradation of acylated ghrelin. At each sampling point,
haemoglobin and haematocrit were measured to permit the assessment of
plasma volume changes.22
Commercially available enzyme-linked immunosorbent assays were
used to determine the concentrations of plasma acylated and desacylated
ghrelin (SPI BIO, Montigny le Bretonneux, France), total PYY, total GLP-1
(Millipore, Billerica, MA, USA), leptin (R&D Systems, Minneapolis, MN, USA)
and insulin (Mercodia, Uppsala, Sweden). Plasma glucose concentrations
were determined by enzymatic, colorimetric methods using a benchtop
analyser (Pentra 400, HORIBA ABX Diagnostics, Montpellier, France). The
within-batch coefﬁcients of variation for the assays were as follows:
acylated ghrelin 5.2%, desacylated ghrelin 4.8%, total PYY 6.1%, total GLP-1
10.2%, leptin 3.0%, insulin 4.5%, and glucose 0.7%.
Statistical analyses
Data were analysed using SPSS Statistics 22.0 (IBM Corporation, Armonk,
NY, USA). Plasma hormone and metabolite concentrations are presented
relative to baseline concentrations (that is, delta) to minimise the potential
inﬂuence of day-to-day biological variation.23,24 Baseline (fasting) plasma
hormone and metabolite concentrations are presented in Supplementary
Table 1. Correction of blood parameters for plasma volume changes did
not alter the results; therefore, unadjusted values are presented. The
homeostasis model assessment of insulin resistance was calculated.25
Linear mixed models were used to examine differences in participant
characteristics and exercise responses with group (lean or overweight/
obese) included as a ﬁxed factor. Baseline (fasting) appetite parameters
and energy/macronutrient intakes were analysed using linear mixed
models with trial (control and exercise) and group included as ﬁxed factors.
Differences in appetite parameters over the 8 h trials were examined using
linear mixed models with trial, time and group included as ﬁxed factors.
Sex was included as a ﬁxed factor in the model for acylated ghrelin
considering that between-sex differences in this hormone have been
reported previously.26 No signiﬁcant between-sex differences were
observed for the other plasma hormones or overall appetite (P⩾ 0.09);
therefore, this data is presented without sex included in the model. All
linear mixed models included a random effect for each participant.
Area under the curve (AUC) values for appetite and blood parameters
were calculated using the trapezoidal rule and are presented in
Supplementary Table 2. Bivariate correlations identifying possible deter-
minants of the exercise-induced changes in AUC values were quantiﬁed
using Pearson’s product moment correlations. Statistical signiﬁcance was
accepted as Po0.05. The 95% conﬁdence intervals (CIs) were calculated
for mean absolute pairwise differences between experimental trials and
groups. Absolute standardised effect sizes (ES) are provided to supplement
important ﬁndings, with 0.2 considered the minimum important
difference, 0.5 moderate and 0.8 large.27 Results are presented as mean
(s.d.) in text and tables and mean (s.e.m.) in ﬁgures (for clarity).
Sample size calculations
Based on previous data from our laboratory,28 it was estimated that a
sample size of 42 participants would have495% power at the 0.05 level to
detect a 188 pg ml− 1 increase in circulating PYY after acute exercise
assuming a s.d.diff of 219 pg ml
− 1. This calculation was conducted using
G*Power (v3.1.9.2).29
RESULTS
Exercise responses
Compared with lean individuals, overweight/obese individuals
exercised at a lower treadmill speed (7.1 (1.4) vs 6.3 (0.9) km h− 1,
respectively; ES = 0.68, P= 0.03) and a marginally lower relative
exercise intensity (60 (3) vs 58 (4)% peak V˙O2, respectively;
ES = 0.56, P= 0.06). No other between-group differences were seen
in exercise responses (P⩾ 0.39; Supplementary Table 3).
Appetite
Overall appetite ratings were similar between groups at baseline
(95% CI − 13.8 to 4.9 mm, P= 0.34) but were lower in the exercise
than in the control trial (95% CI − 11.2 to − 0.4 mm, ES = 0.34,
P= 0.04) (Figure 1). Linear mixed models for overall appetite
identiﬁed a main effect of trial (P= 0.01) and time (Po0.001) but
not group (95% CI − 7.4 to 4.4 mm, P= 0.60) (Figure 1). The main
effect of trial revealed lower overall appetite in the exercise than
in the control trial (95% CI − 3.1 to − 0.5 mm, ES = 0.07, P= 0.01).
Analysis also revealed a signiﬁcant trial-by-time interaction
(Po0.001), with lower overall appetite in exercise than in control
at 0.5, 1.0 and 1.5 h (all ES⩾ 0.60, P⩽ 0.001). The magnitude of
reduction in overall appetite after exercise was marginally albeit
signiﬁcantly different between the overweight/obese and lean
participants (−0.1 mm (ESo0.01) vs − 3.5 mm (ES = 0.14), respec-
tively; trial-by-group interaction P= 0.01).
Energy and macronutrient intakes
Absolute energy and macronutrient intakes were similar across
trials and groups (main effect trial P⩾ 0.17; main effect group
P⩾ 0.24; trial-by-group interaction P⩾ 0.20; Table 2). Linear mixed
models for relative energy intake (absolute energy intake minus
the net energy expenditure of exercise) revealed a main effect of
trial (Po0.001) but not group (P= 0.41) or trial-by-group
interaction (P= 0.60) (Table 2). The main effect of trial revealed
Figure 1. Overall appetite perceptions in the lean (n= 22, left panel) and overweight/obese (n= 25, right panel) individuals during the control
(■) and exercise (J) trials. Values are mean (s.e.m.). Grey rectangle indicates exercise, open rectangles indicate standardised meals and black
rectangle indicates ad libitum buffet meal.
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lower relative energy intake in the exercise than in the control trial
(ES = 1.26, Po0.001).
Plasma hormone and metabolite concentrations
Owing to problems with venous cannulation, data for concentra-
tions of plasma ghrelin, insulin and glucose are presented for
n= 43 (lean: n= 20; overweight/obese: n= 23), total PYY for n= 42
(lean: n= 20; overweight/obese: n= 22) and total GLP-1 for n= 40
(lean: n= 18; overweight/obese: n= 22).
Acylated ghrelin. Fasting acylated ghrelin concentrations at
baseline were not different between trials (95% CI − 7 to
13 pg ml− 1, P= 0.61) or between lean and overweight/obese
individuals (95% CI − 36 to 69 pg ml− 1, P= 0.53) but were higher
in women than in men (95% CI 5 to 110 pg ml− 1, ES = 0.72,
P= 0.03). Linear mixed models for delta acylated ghrelin identiﬁed
a main effect of time (Po0.001) and sex (P= 0.02) but no trial,
group or interaction effects (P⩾ 0.37) (Figure 2). The main effect of
sex revealed lower delta acylated ghrelin concentrations in
women than in men (95% CI − 57 to − 6 pg ml− 1, ES = 0.64,
P= 0.02).
Desacylated ghrelin. Fasting desacylated ghrelin concentrations
were similar across trials and groups at baseline (main effect trial
P= 0.37; main effect group P= 0.27; trial-by-group interaction
P= 0.55). Linear mixed models for delta desacylated ghrelin
identiﬁed a main effect of trial (P= 0.01) and time (Po0.001)
but not group (95% CI − 201 to 66 pg ml− 1, P= 0.31) (Figure 3a).
The main effect of trial revealed lower delta desacylated ghrelin
concentrations in the exercise than in the control trial (95% CI − 48
to − 6 pg ml− 1, ES = 0.14, P= 0.01). The magnitude of reduction in
delta desacylated ghrelin concentrations after exercise was
greater in overweight/obese than in lean individuals
(−54.1 pg ml− 1 (ES = 0.21) vs − 0.3 pg ml− 1 (ESo0.01), respec-
tively; trial-by-group interaction P= 0.01).
Total PYY. Fasting total PYY concentrations were similar across
trials and groups at baseline (main effect trial P= 0.12; main effect
group P= 0.56; trial-by-group interaction P= 0.39). Linear mixed
models for delta total PYY identiﬁed a main effect of trial
(Po0.001) and time (Po0.001) but not group (95% CI − 22 to
9 pg ml− 1, P= 0.40) (Figure 3b). The main effect of trial revealed
higher delta total PYY concentrations in the exercise than in the
control trial (95% CI 10 to 17 pg ml− 1, ES = 0.32, Po0.001). The
magnitude of increase in delta total PYY concentrations after
exercise was lower in overweight/obese than in lean individuals
(6.4 pg ml− 1 (ES = 0.14) vs 21.3 pg ml− 1 (ES = 0.56), respectively;
trial-by-group interaction Po0.001).
Total GLP-1. Fasting total GLP-1 concentrations were similar
across trials and groups at baseline (main effect trial P= 0.33; main
effect group P= 0.80; trial-by-group interaction P= 0.62). Linear
Table 2. Ad libitum energy and macronutrient intakes at the buffet meal in the control and exercise trials
Lean (n=22a) Overweight/obese (n=25) Control vs exercise 95% CIb Lean vs overweight/obese 95% CIb
Control Exercise Control Exercise
Absolute energy intake (kJ) 3183 (1389) 3062 (1730) 3465 (1572) 3542 (1791) − 391 to 346 − 507 to 1268
Relative energy intake (kJ) 3223 (1410) 1231 (1628) 3465 (1572) 1684 (1585) − 2290 to − 1483c − 487 to 1182
Fat intake (g) 35.1 (16.6) 32.9 (19.6) 40.4 (23.7) 39.2 (25.0) − 7.1 to 3.6 − 5.8 to 17.4
Fat intake (%) 42 (10) 40 (9) 42 (12) 42 (10) − 3 to 1 − 4 to 7
Carbohydrate intake (g) 88.2 (47.9) 83.9 (54.9) 85.9 (39.7) 94.6 (47.6) − 8.0 to 12.3 − 21.9 to 30.3
Carbohydrate intake (%) 45 (10) 47 (11) 43 (12) 45 (13) − 1 to 5 − 9 to 4
Protein intake (g) 22.9 (10.7) 25.1 (22.4) 30.2 (14.9) 28.8 (19.3) − 3.6 to 4.4 − 3.9 to 14.9
Protein intake (%) 13 (7) 13 (9) 15 (6) 13 (7) − 3 to 1 − 2 to 4
Abbreviation: CI, conﬁdence interval. All values are mean (s.d.). aRelative energy intake available for n= 21 due to missing data for net energy expenditure.
b95% conﬁdence interval of the mean absolute difference between the trials or groups. cSigniﬁcant difference between control and exercise trials (Po0.001).
Figure 2. Plasma concentrations of delta acylated ghrelin in the lean (left panel) and overweight/obese (right panel) individuals during the
control (■ male; ● female) and exercise (□ male; J female) trials. Values are mean (s.e.m.), n= 10 lean men, n= 12 overweight/obese men,
n= 10 lean women and n= 11 overweight/obese women. Grey rectangle indicates exercise, open rectangles indicate standardised meals and
black rectangle indicates ad libitum buffet meal.
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mixed models for delta total GLP-1 identiﬁed a main effect of trial
(Po0.001) and time (Po0.001) but not group (95% CI –3 to
11 pmol l− 1, P= 0.27) (Figure 3c). The main effect of trial revealed
higher delta total GLP-1 concentrations in the exercise than in the
control trial (95% CI 7 to 10 pmol l− 1, ES = 0.63, Po0.001). Analysis
also revealed a signiﬁcant trial-by-time interaction (P= 0.001), with
higher delta total GLP-1 concentrations in exercise than in control
at 1.5, 2.25, 2.75, 3.25, 7 and 8 h (all ES⩾ 0.55, P⩽ 0.008). The
magnitude of increase in delta total GLP-1 concentrations after
exercise was greater in overweight/obese than in lean individuals
(10.6 pmol l− 1 (ES = 0.88) vs 6.1 pmol l− 1 (ES = 0.41), respectively;
trial-by-group interaction P= 0.01).
Insulin. Fasting insulin concentrations were similar across trials
and groups at baseline (main effect trial P= 0.92; main effect
group P= 0.23; trial-by-group interaction P= 0.70). Linear mixed
models for delta insulin identiﬁed a main effect of trial (Po0.001),
time (Po0.001), group (P= 0.03) and group-by-time interaction
(P= 0.002) (Figure 4a). The main effects of trial and group revealed
that delta insulin concentrations were higher in the control than in
the exercise trial (95% CI 12 to 37 pmol l− 1, ES = 0.15, Po0.001)
and in overweight/obese than in lean individuals (95% CI 6 to
85 pmol l− 1, ES = 0.28, P= 0.03). Post hoc analysis of the group-by-
time interaction revealed higher delta insulin concentrations in
overweight/obese than in lean individuals at 2.25, 2.75, 4.75 and
8 h (all ES⩾ 0.43, P⩽ 0.05).
Glucose. Fasting glucose concentrations at baseline were similar
between trials (95% CI − 0.17 to 0.05 mmol l− 1, P= 0.27) but were
higher in overweight/obese than in lean individuals (95% CI 0.03
to 0.60 mmol l− 1, ES = 0.56, P= 0.03). Delta glucose concentrations
were similar across trials and groups (main effect trial P= 0.11;
main effect group P= 0.46; trial-by-group interaction P= 0.15)
(Figure 4b).
Figure 3. Plasma concentrations of delta desacylated ghrelin (a, top panels), delta total PYY (b, middle panels) and delta total GLP-1 (c, bottom
panels) in the lean (left panels) and overweight/obese (right panels) individuals during the control (■) and exercise (J) trials. Values are mean
(s.e.m.), n= 43 for desacylated ghrelin, n= 42 for total PYY and n= 40 for total GLP-1. Grey rectangle indicates exercise, open rectangles
indicate standardised meals and black rectangle indicates ad libitum buffet meal.
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Correlations
A positive correlation was identiﬁed between exercise-induced
changes in AUC values for delta acylated and desacylated ghrelin
concentrations (r = 0.55, Po0.001) and delta insulin and glucose
concentrations (r = 0.48, P= 0.001). There were no signiﬁcant
correlations between exercise-induced changes in AUC values
for delta appetite-regulatory hormone concentrations and overall
appetite or ad libitum energy intake (P⩾ 0.14).
DISCUSSION
The primary ﬁndings from this study were that a single bout of
moderate-intensity exercise transiently suppressed appetite and
increased concentrations of total PYY and GLP-1 but did not
stimulate compensatory changes in appetite or energy intake on
the same day in lean and overweight/obese individuals. There was
remarkably little difference in appetite, ad libitum energy intake
and appetite-regulatory hormone concentrations between lean
and overweight/obese individuals. Subtle differences in appetite
hormone responses to exercise were, however, detected between
the groups, with overweight/obese individuals experiencing a
greater exercise-induced suppression in desacylated ghrelin and
elevation in total GLP-1, whereas lean individuals experienced a
greater increase in total PYY after exercise. These ﬁndings refute
the hypothesis that overweight/obese individuals exhibit greater
compensatory changes in subjective and homeostatic mediators
of appetite in response to acute exercise-induced energy deﬁcits.
To the authors’ knowledge, only two previous studies have
directly compared appetite-regulatory hormone responses to
acute exercise between lean and overweight/obese
individuals.11,30 In line with the ﬁndings of Ueda et al.,11
appetite-regulatory hormone proﬁles were largely similar between
the groups in this study with the exception of the anticipated
greater meal-induced perturbations in insulin concentrations in
overweight/obese individuals. This contrasts the ﬁndings of
Marzullo et al.30 who observed lower fasting concentrations of
total and acylated ghrelin in obese compared with lean
individuals. Furthermore, previous non-exercise studies have
demonstrated that obese individuals exhibit a diminished meal-
induced increase in PYY and GLP-1 concentrations4,5 and reduced
postprandial suppression of acylated ghrelin6 compared with
healthy, lean individuals. This inconsistency in ﬁndings is most
likely explained by differences in the range of BMI values adopted
to distinguish adiposity status coupled with key variations in study
design. Speciﬁcally, appetite-regulatory hormone concentrations
are inﬂuenced by factors such as diet standardisation, meal energy
content and/or macronutrient composition, sample processing
and the form of circulating gut peptide quantiﬁed.31
Despite the comparable appetite-regulatory hormone concen-
trations between groups, subtle differences in the magnitude of
change in the hormone proﬁles after exercise emerged and
represent a novel ﬁnding from this study. Speciﬁcally, the exercise-
induced suppression of circulating desacylated ghrelin and
elevation in total GLP-1 were greater in overweight/obese
individuals, whereas lean individuals experienced a greater
increase in total PYY after exercise. This contrasts previous
ﬁndings suggesting that acute exercise elicits a similar increase
in total PYY and GLP-17–36 in lean and overweight/obese men.
11
However, it is possible that the short follow-up after exercise in the
study by Ueda et al.11 (1 vs 7 h in this study) precluded any
between-group differences in the response of these appetite-
regulatory hormones to exercise becoming apparent.
A potential explanation for the divergent appetite hormone
response to exercise between groups in this study may reﬂect
Figure 4. Plasma concentrations of delta insulin (a, top panels) and delta glucose (b, bottom panels) in the lean (left panels) and overweight/
obese (right panels) individuals during the control (■) and exercise (J) trials. Values are mean (s.e.m.), n= 43 for insulin and glucose. Grey
rectangle indicates exercise, open rectangles indicate standardised meals and black rectangle indicates ad libitum buffet meal.
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differences in body composition and insulin resistance. Along with
regulating glucose metabolism, insulin acts as a chronic mediator
of energy homeostasis and has also been implicated in short-term
appetite regulation.32,33 The lower insulin concentrations after
exercise in the absence of a change in circulating glucose points
to an acute improvement in insulin sensitivity in both lean and
overweight/obese individuals, which represents a well-established
effect of acute exercise.34 Insulin resistance increases with
adiposity and has been associated previously with disrupted
postprandial satiety signalling,35 lower acylated ghrelin concen-
trations independent of weight status36 and impaired meal-
induced incretin hormone secretion (for example, GLP-1).37 GLP-1
exerts anorexigenic effects via central appetite-regulating path-
ways and augments the insulin response to nutrient intake to
regulate postprandial glucose excursions.33,38,39 Therefore, the
greater exercise-induced elevation in total GLP-1 in overweight/
obese individuals may point to enhanced postprandial satiety
signalling and nutrient sensing in these individuals. However, PYY
is co-secreted with GLP-1 from the intestinal L-cells,40 yet
circulating total PYY concentrations were increased to a greater
extent after exercise in lean individuals. Furthermore, no mean-
ingful associations emerged between exercise-induced changes in
appetite, energy intake or appetite-regulatory hormones that may
explain these differences. Consequently, the implications of these
ﬁndings remain unclear and further work is required to ascertain
whether appetite hormone responses to exercise differ according
to adiposity status.
Consistent with previous research, there was a marked
suppression of appetite during and immediately after exercise
that coincided with elevated total PYY and GLP-1 concentrations
in the hours after exercise.1,2 These outcomes occurred with a
concomitant exercise-induced suppression in desacylated, but not
in acylated, ghrelin concentrations. This ﬁnding is surprising
considering the consensus of evidence suggests that acylated
ghrelin concentrations are transiently suppressed during and
immediately after single bouts of exercise.2,41 It is possible that the
exercise intensity in this study (59% peak V˙O2) was insufﬁcient to
elicit the transient suppression in acylated ghrelin typically
reported elsewhere in the literature when the exercise intensity
exceeds 65% peak V˙O2.
24,28,42,43 In this regard, low-intensity
cycling and walking (~50% peak V˙O2) does not inﬂuence acylated
ghrelin concentrations,11,44 and exercise intensity has been
identiﬁed as an important determinant of the acylated ghrelin
response to exercise.45,46 Nevertheless, the exercise protocol
adopted in this study failed to provoke any compensatory
changes in appetite or appetite-regulatory hormones in the hours
after exercise, supporting previous studies in lean23,24,28,42,43 and
overweight/obese8–11 individuals.
Despite exercise inducing transient changes in subjective and
hormonal appetite parameters, ad libitum absolute energy and
macronutrient intakes were similar between trials and groups 6 h
after exercise cessation. This corroborates previous ﬁndings
demonstrating no change in energy intake at meals provided on
the day of exercise in lean23,24,28,43 and overweight/obese7,10,47
individuals. Furthermore, direct comparisons of lean and over-
weight/obese individuals have reported that energy intake in the
immediate postexercise period (⩽1 h postexercise) is unchanged12
or reduced11 in both groups. Collectively, these ﬁndings suggest
that exercise can induce a short-term energy deﬁcit in lean and
overweight/obese individuals. This refutes the hypothesis that
overweight/obese individuals are more likely to exhibit physiolo-
gical compensatory responses to acute exercise-induced energy
deﬁcits and may have important implications regarding the use of
exercise in weight control and energy homeostasis.
Exploratory analysis of potential sex-based differences revealed
higher fasting acylated ghrelin concentrations in women than in
men, a ﬁnding that has been replicated previously and shown to
persist across the 7 h experimental trial.26 In contrast, acylated
ghrelin concentrations across the 8 h trial were lower in women
than in men in this study. This disparity most likely reﬂects the
differing statistical approaches adopted with concentrations
analysed relative to baseline levels (delta) in this study but as
absolute concentrations in the study by Alajmi et al.26 Further-
more, a closer examination of our data identiﬁed higher acylated
ghrelin concentrations in women than in men when analysed as
absolute concentrations (data not shown). It has been suggested
previously that women may exhibit greater exercise-induced
compensatory responses in the appetite control system than men
to preserve body fat stores, energy balance and reproductive
function.48 However, in contrast to this hypothesis, men and
women exhibited a similar acylated ghrelin response to exercise in
this study that is consistent with previous evidence demonstrating
equivalent physiological responses in the homeostatic regulation
of appetite to acute and chronic exercise-induced energy deﬁcits
between the sexes.26,49
This investigation is limited by the provision of the ad libitum
buffet meal 3 h after the standardised lunch before appetite
values had returned to baseline levels. Although similar to
previous study designs,24,28 this pattern of meal provision may
inﬂuence energy intake through non-homeostatic drivers of
appetite. Additionally, participants were not familiarised with the
ad libitum buffet meal before the experimental trials. The provision
of a wide selection of foods may promote overconsumption and
reduce the ability to identify exercise-induced changes in energy/
macronutrient intakes. A further limitation concerns the use of BMI
to deﬁne weight status, which does not account for differences in
fat and fat-free mass,50 and combining the data for overweight
and obese individuals may reduce the ability to detect between-
group differences. However, further statistical analyses stratifying
weight status according to waist circumference or body fat
percentage and comparing distinct groups using the bottom and
top tertiles of BMI, waist circumference and body fat percentage
revealed comparable ﬁndings to those presented for the lean and
overweight/obese individuals deﬁned using BMI cut points.
Nevertheless, despite these limitations, our ﬁndings provide
important insights into appetite responses to acute exercise in
lean and overweight/obese individuals.
In conclusion, a single session of moderate-intensity exercise
transiently suppressed appetite and increased total PYY and GLP-1
concentrations after exercise in lean and overweight/obese
individuals. Furthermore, exercise did not provoke any compen-
satory perturbations in energy intake or subjective and hormonal
appetite regulation in either group, thereby maintaining the
exercise-induced energy deﬁcit on the day of exercise. These
ﬁndings support the promotion of exercise as a method for
inducing a short-term negative energy balance in lean and
overweight/obese individuals.
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